CHICAGO, Jan. 28, 2021 /PRNewswire/ — Like most health data analytics organizations, Blue Health Intelligence® (BHI®) was laser-focused on COVID-19 last year. Still, a compendium of its research briefs from a busy 2020 serves as a reminder that COVID leads an array of clinical care challenges facing the U.S. healthcare system.
Using its National Data Repository, which reflects the care experiences of 217 million unique health plan members with over 22 billion claims, BHI examined childhood obesity, human papillomavirus virus (HPV) rates, men’s health challenges, skin cancer rates, and the effect of the pandemic on preventive care and telehealth.
Specifically, the BHI 2020 Year-End Data Digest reveals that:
“BHI is honored to provide trend reporting to help the larger healthcare ecosystem identify where additional study and/or interventions might benefit individuals and organizations,” said its CEO, Swati Abbott.
About Blue Health Intelligence
Blue Health Intelligence® (BHI®) delivers insights that empower healthcare organizations to improve care, reduce costs, and optimize performance. BHI’s team of data analysts, clinicians, IT experts, and epidemiologists provide analytics, software-as-a-service, and in-depth consulting to payers, providers, employers, medical device companies, and other healthcare stakeholders. BHI is an independent licensee of the Blue Cross Blue Shield Association and carries the trade name of Health Intelligence Company, LLC.
View original content to download multimedia:http://www.prnewswire.com/news-releases/bhi-data-briefs-paint-a-picture-of-current-healthcare-dynamics-in-the-us-301216739.html
SOURCE Blue Health Intelligence
GENEVA, SWITZERLAND / ACCESS Newswire / December 15, 2025 / MindMaze Therapeutics Holding SA (SIX:MMTX)…
Milestone enables GMP manufacturing to accelerate clinical trials and transform global vaccine delivery BRISBANE, Australia…
BEIJING, Dec. 14, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading…
12 Month Timeline - How Cannabis Rescheduling Actually Takes EffectAnnouncementPresident signals intent or issues executive…
First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel…
NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- TrialWire®, the industry’s fastest, intelligent patient recruitment…